Serological testing versus other strategies for diagnosis of active tuberculosis in India: a cost-effectiveness analysis
GHDx Entry last modified on: Apr 10, 2023
Health care costs
Dataset Records for Health care costs
Displaying 151 - 200 of 509
Finding a needle in the haystack: the costs and cost-effectiveness of syphilis diagnosis and treatment during pregnancy to prevent congenital syphilis in Kalomo District of Zambia
GHDx Entry last modified on: Apr 10, 2023
Benin Health Statistical Yearbook 2010
Annuaire des Statistiques Sanitaires 2010
Report:
Epi surveillance - Subnationally representative - Urban-rural representative
Rapid Syphilis Testing Is Cost-Effective Even in Low-Prevalence Settings: The CISNE-PERU Experience
GHDx Entry last modified on: Apr 10, 2023
Cost and cost-effectiveness of multidrug-resistant tuberculosis treatment in Estonia and Russia
GHDx Entry last modified on: Apr 10, 2023
Germany Diagnosis-Related Group Catalog 2010
Fallpauschalen-Katalog 2010
Administrative data:
Financial - Operational
United States MarketScan Medicare Supplemental and Coordination of Benefits Database 2010
Administrative data:
Discharge - Emergency - Financial - Inpatient - Outpatient
Comparing cost-effectiveness of standardised tuberculosis treatments given varying drug resistance
GHDx Entry last modified on: Apr 10, 2023
United States MarketScan Commercial Claims and Encounters Database 2010
Administrative data:
Discharge - Emergency - Financial - Inpatient - Outpatient
Cost-effectiveness analysis of initial HIV treatment under Italian guidelines
GHDx Entry last modified on: Apr 10, 2023
Cost-effectiveness of optimized background therapy plus maraviroc for previously treated patients with R5 HIV-1 infection from the perspective of the Spanish health care system
GHDx Entry last modified on: Apr 10, 2023
Cost-effectiveness of adding an agent that improves immune responses to initial antiretroviral therapy (ART) in HIV-infected patients: guidance for drug development
GHDx Entry last modified on: Apr 10, 2023
Cost-effectiveness of voluntary HIV screening in Russia
GHDx Entry last modified on: Apr 10, 2023
Economic savings versus health losses: the cost-effectiveness of generic antiretroviral therapy in the United States
GHDx Entry last modified on: Apr 10, 2023
Vietnam Health Statistics Yearbook 2013
Niên giám thống kê y tế 2013
Report:
Financial - Subnationally representative
Palestine Health Status Annual Report 2015
Health Annual Report Palestine 2015
Report:
Epi surveillance - Subnationally representative
Cost-effectiveness of interferon- release assay versus chest X-ray for tuberculosis screening of employees
GHDx Entry last modified on: Apr 10, 2023
The cost effectiveness of rotavirus vaccination in Iran
GHDx Entry last modified on: Jan 28, 2023
The cost-effectiveness of symptom-based testing and routine screening for acute HIV infection in men who have sex with men in the USA
GHDx Entry last modified on: Apr 10, 2023
Cost-effectiveness of targeted human immunodeficiency virus screening in an urban emergency department
GHDx Entry last modified on: Apr 10, 2023
Making wider use of the world's most widely used vaccine: Bacille Calmette-Guerin revaccination reconsidered
GHDx Entry last modified on: Apr 10, 2023
Cost and cost-effectiveness of switching from d4T or AZT to a TDF-based first-line regimen in a resource-limited setting in rural Lesotho
GHDx Entry last modified on: Apr 10, 2023
Bahrain Health Statistics 2009
GHDx Entry last modified on: Mar 4, 2024
Cost-effectiveness of rotavirus vaccination in peru
GHDx Entry last modified on: Jan 28, 2023
Cost-effectiveness analysis of a universal rotavirus immunization program in Japan
GHDx Entry last modified on: Jan 28, 2023
Cost-effectiveness analysis of vaccinating children in Malawi with RTS,S vaccines in comparison with long-lasting insecticide-treated nets
GHDx Entry last modified on: Apr 10, 2023
Is home management of fevers a cost-effective way of reducing under-five mortality in Africa? The case of a rural Ghanaian District
GHDx Entry last modified on: Apr 10, 2023
Bahrain Health Statistics 2013
Report:
Epi surveillance - Subnationally representative
Cost effectiveness of darunavir/ritonavir 600/100 mg bid in treatment-experienced, lopinavir-naive, protease inhibitor-resistant, HIV-infected adults in Belgium, Italy, Sweden and the UK
GHDx Entry last modified on: Apr 10, 2023
Resource utilization and cost-effectiveness of counselor- vs. provider-based rapid point-of-care HIV screening in the emergency department
GHDx Entry last modified on: Apr 10, 2023
Cost effectiveness of darunavir/ritonavir 600/100 mg bid in protease inhibitor-experienced, HIV-1-infected adults in Belgium, Italy, Sweden and the UK
GHDx Entry last modified on: Apr 10, 2023
The epidemiological impact and cost-effectiveness of HIV testing, antiretroviral treatment and harm reduction programs
GHDx Entry last modified on: Apr 10, 2023
Health economics of rotavirus immunization in Vietnam: potentials for favorable cost-effectiveness in developing countries
GHDx Entry last modified on: Jan 28, 2023
Targeted BCG vaccination against severe tuberculosis in low-prevalence settings: epidemiologic and economic assessment
GHDx Entry last modified on: Apr 10, 2023
The cost-effectiveness and population outcomes of expanded HIV screening and antiretroviral treatment in the United States
GHDx Entry last modified on: Apr 10, 2023
Oman Annual Health Report 2009
GHDx Entry last modified on: May 1, 2023
Benin Health Statistical Yearbook 2009
Annuaire des Statistiques Sanitaires 2009
Report:
Epi surveillance - Subnationally representative - Urban-rural representative
Cost-effectiveness of pre-exposure prophylaxis targeted to high-risk serodiscordant couples as a bridge to sustained ART use in Kampala, Uganda
GHDx Entry last modified on: Apr 10, 2023
Cost effectiveness of screening strategies for early identification of HIV and HCV infection in injection drug users
GHDx Entry last modified on: Apr 10, 2023
Germany Diagnosis-Related Group Catalog 2009
Fallpauschalen-Katalog 2009
Administrative data:
Financial - Operational
Palestine Health Status Annual Report 2016
Health Annual Report Palestine 2016
Report:
Epi surveillance - Subnationally representative
Antiretroviral therapy in HIV-infected patients: a proposal to assess the economic value of the single-tablet regimen
GHDx Entry last modified on: Apr 10, 2023
HIV screening via fourth-generation immunoassay or nucleic acid amplification test in the United States: a cost-effectiveness analysis
GHDx Entry last modified on: Apr 10, 2023
Dominican Republic National Multipurpose Household Survey 2008
Encuesta Nacional de Hogares de Propósitos Múltiples 2008
Survey:
De facto - De jure - Household - Interview - Sample registration - Subnationally representative - Urban-rural representative
Mexico National Survey of Health Spending 2008
Encuesta Nacional de Gasto en Salud (ENAGAS) 2008
Survey:
Cross-sectional - Household - Individual - Interview - Nationally representative - Subnationally representative - Urban-rural representative
Treatment outcomes, health-care resource utilization and costs of bortezomib and dexamethasone, with cyclophosphamide or lenalidomide, in newly diagnosed multiple myeloma
GHDx Entry last modified on: Mar 19, 2021
Projected impact and cost-effectiveness of a rotavirus vaccination program in India, 2008
GHDx Entry last modified on: Jan 28, 2023
Bahrain Health Statistics 2008
Report:
Discharge - Inpatient - Outpatient
Cost effectiveness of pomalidomide in patients with relapsed and refractory multiple myeloma in Sweden
GHDx Entry last modified on: Mar 19, 2021
Cost-effectiveness of rotavirus vaccination in the Netherlands; the results of a consensus model
GHDx Entry last modified on: Jan 28, 2023
Subscribe